CA
SRTA

Cliff Asness’s Strata Critical Medical Inc SRTA Stock Holding History

Cliff Asness’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$736K Buy
139,622
+7,481
+6% +$39.4K ﹤0.01% 3182
2026
Q1 		$552K Sell
132,141
-7,067
-5% -$34K ﹤0.01% 3077
2025
Q4 		$670K Sell
139,208
-10,846
-7% -$52.5K ﹤0.01% 2768
2025
Q3 		$759K Sell
150,054
-11,537
-7% -$51K ﹤0.01% 2590
2025
Q2 		$651K Sell
161,591
-45,456
-22% -$148K ﹤0.01% 2466
2025
Q1 		$565K Sell
207,047
-40,640
-16% -$146K ﹤0.01% 2357
2024
Q4 		$1.05M Sell
247,687
-257,722
-51% -$981K ﹤0.01% 1866
2024
Q3 		$1.49M Sell
505,409
-41,221
-8% -$131K ﹤0.01% 1643
2024
Q2 		$1.9M Buy
546,630
+162,867
+42% +$543K ﹤0.01% 1467
2024
Q1 		$1.09M Buy
383,763
+228,837
+148% +$706K ﹤0.01% 1648
2023
Q4 		$547K Buy
+154,926
New +$445K ﹤0.01% 1845
2023
Q2 		– Sell
-62,085
Closed -$210K – 2194
2023
Q1 		$210K Buy
62,085
+24,309
+64% +$99.1K ﹤0.01% 2042
2022
Q4 		$135K Buy
+37,776
New +$161K ﹤0.01% 2116

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cliff Asness's SRTA Position: Q2 2026 in Review

Cliff Asness increased its Strata Critical Medical Inc (SRTA) stake by 5.7% in Q2 2026, buying an estimated $39.4K and bringing the position to 139,622 shares worth $736K. The position accounts for ﹤0.01% of the portfolio, ranked #3182.

Cliff Asness first reported a position in SRTA in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.9M in Q2 2024. 138 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Cliff Asness held 139,622 shares of Strata Critical Medical Inc worth $736K as of Q2 2026.
  • Cliff Asness bought 7,481 Strata Critical Medical Inc shares in Q2 2026, an estimated $39.4K.
  • Strata Critical Medical Inc made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3182 holding.
  • Cliff Asness first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 13 quarters since.
  • Cliff Asness's Strata Critical Medical Inc position peaked at $1.9M in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.